Johannes Laengle
-
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 5
- Colorectal Cancer Treatments and Studies 5
- Colorectal Cancer Surgical Treatments 5
- HER2/EGFR in Cancer Research 3
-
- Virus-based gene therapy research 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Michael BergmannMonika SachetBranka PetričevićGuenther G. StegerRupert BartschJudit FazekasErika Jensen‐JarolimJosef Singer
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- AustriaUnited KingdomRussia
In The Last Decade
Johannes Laengle
24 papers receiving 500 citations
Peers
Comparison fields: 5 of 69
- Immunology 183
- Oncology 227
- Cancer Research 61
- Radiology, Nuclear Medicine and Imaging 90
- Molecular Biology 181
Countries citing papers authored by Johannes Laengle
This map shows the geographic impact of Johannes Laengle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Laengle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Laengle more than expected).
Fields of papers citing papers by Johannes Laengle
This network shows the impact of papers produced by Johannes Laengle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Laengle. The network helps show where Johannes Laengle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Johannes Laengle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 13 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 20 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 34 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 21 | |
| 14 | 2018 | 23 | |
| 15 | 2018 | 18 | |
| 16 | 2017 | 87 | |
| 17 | 2016 | 18 | |
| 18 | 2016 | 33 | |
| 19 | 2015 | 17 | |
| 20 | 2013 | 148 |
About Johannes Laengle
Johannes Laengle is a scholar working on Oncology, Hepatology and Physiology, having authored 25 papers that have together received 505 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (5 papers), Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers), Virus-based gene therapy research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Immunology (183 citations), Oncology (227 citations) and Cancer Research (61 citations). Johannes Laengle has collaborated with scholars based in Austria, United Kingdom and Russia. Frequent co-authors include Michael Bergmann, Monika Sachet, Branka Petričević, Guenther G. Steger, Rupert Bartsch, Judit Fazekas, Erika Jensen‐Jarolim, Josef Singer, Philipp Starkl and Oswald Wagner. Their work appears in journals such as Journal of Clinical Oncology, HPB, Cell Metabolism, Scientific Reports and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.